These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 16715137

  • 1. Human melanoma cells expressing V600E B-RAF are susceptible to IGF1R targeting by small interfering RNAs.
    Yeh AH, Bohula EA, Macaulay VM.
    Oncogene; 2006 Oct 26; 25(50):6574-81. PubMed ID: 16715137
    [Abstract] [Full Text] [Related]

  • 2. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
    Babchia N, Calipel A, Mouriaux F, Faussat AM, Mascarelli F.
    Invest Ophthalmol Vis Sci; 2010 Jan 26; 51(1):421-9. PubMed ID: 19661225
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
    Calleros L, Sánchez-Hernández I, Baquero P, Toro MJ, Chiloeches A.
    Carcinogenesis; 2009 Oct 26; 30(10):1670-7. PubMed ID: 19700418
    [Abstract] [Full Text] [Related]

  • 5. 17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines.
    Babchia N, Calipel A, Mouriaux F, Faussat AM, Mascarelli F.
    Invest Ophthalmol Vis Sci; 2008 Jun 26; 49(6):2348-56. PubMed ID: 18281615
    [Abstract] [Full Text] [Related]

  • 6. Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines.
    Bloethner S, Chen B, Hemminki K, Müller-Berghaus J, Ugurel S, Schadendorf D, Kumar R.
    Carcinogenesis; 2005 Jul 26; 26(7):1224-32. PubMed ID: 15760917
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Targeting NRAS in melanoma.
    Kelleher FC, McArthur GA.
    Cancer J; 2012 Jul 26; 18(2):132-6. PubMed ID: 22453013
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. siRNA-mediated type 1 insulin-like growth factor receptor silencing induces chemosensitization of a human liver cancer cell line with mutant P53.
    Niu J, Xu Z, Li XN, Han Z.
    Cell Biol Int; 2007 Feb 26; 31(2):156-64. PubMed ID: 17097318
    [Abstract] [Full Text] [Related]

  • 12. Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation.
    Wellbrock C, Marais R.
    J Cell Biol; 2005 Aug 29; 170(5):703-8. PubMed ID: 16129781
    [Abstract] [Full Text] [Related]

  • 13. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
    Ulivi P, Arienti C, Amadori D, Fabbri F, Carloni S, Tesei A, Vannini I, Silvestrini R, Zoli W.
    J Cell Physiol; 2009 Jul 29; 220(1):214-21. PubMed ID: 19288493
    [Abstract] [Full Text] [Related]

  • 14. Suppression of BRAF/MEK/MAP kinase pathway restores expression of iodide-metabolizing genes in thyroid cells expressing the V600E BRAF mutant.
    Liu D, Hu S, Hou P, Jiang D, Condouris S, Xing M.
    Clin Cancer Res; 2007 Feb 15; 13(4):1341-9. PubMed ID: 17317846
    [Abstract] [Full Text] [Related]

  • 15. B-Raf(V600E) signaling deregulates the mitotic spindle checkpoint through stabilizing Mps1 levels in melanoma cells.
    Cui Y, Guadagno TM.
    Oncogene; 2008 May 15; 27(22):3122-33. PubMed ID: 18071315
    [Abstract] [Full Text] [Related]

  • 16. Growth factors rescue cutaneous melanoma cells from apoptosis induced by knockdown of mutated (V 600 E) B-RAF.
    Christensen C, Guldberg P.
    Oncogene; 2005 Sep 15; 24(41):6292-302. PubMed ID: 16007203
    [Abstract] [Full Text] [Related]

  • 17. Is B-Raf a good therapeutic target for melanoma and other malignancies?
    Madhunapantula SV, Robertson GP.
    Cancer Res; 2008 Jan 01; 68(1):5-8. PubMed ID: 18172288
    [Abstract] [Full Text] [Related]

  • 18. KIT pathway alterations in mucosal melanomas of the vulva and other sites.
    Omholt K, Grafström E, Kanter-Lewensohn L, Hansson J, Ragnarsson-Olding BK.
    Clin Cancer Res; 2011 Jun 15; 17(12):3933-42. PubMed ID: 21680547
    [Abstract] [Full Text] [Related]

  • 19. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis.
    Chetoui N, Sylla K, Gagnon-Houde JV, Alcaide-Loridan C, Charron D, Al-Daccak R, Aoudjit F.
    Mol Cancer Res; 2008 Jan 15; 6(1):42-52. PubMed ID: 18234961
    [Abstract] [Full Text] [Related]

  • 20. Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway.
    Gollob JA, Wilhelm S, Carter C, Kelley SL.
    Semin Oncol; 2006 Aug 15; 33(4):392-406. PubMed ID: 16890795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.